Search
CEL-SCI Corp
CVMAdd to Watchlist
1.045USD
+0.005+0.48%
Market hours （ET）Quotes delayed by 15 min
8.87MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30The current earnings forecast score of CEL-SCI Corp is 8.00, ranking 165 out of 387 in the Biotechnology & Medical Research industry. The average price target is 300.00, with a high of 300.00 and a low of 300.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
25.000
Target Price
+2214.81%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
CEL-SCI Corp
CVM
1
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is CEL-SCI Corp's price target?
Analysts forecast that CEL-SCI Corp's price target is USD 300.00, with the highest forecast at USD 300.00 and the lowest forecast at USD 300.00.
What is the analyst rating for CEL-SCI Corp?
Based on the ratings of CEL-SCI Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.